Regulation of tissue inhibitor of matrix metalloproteinase expression.
Overall
C M
CM
Faculty of Dentistry, University of British Columbia, Vancouver, Canada.
D000328:Adult; D000818:Animals; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism*; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D005333:Fetus; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D005881:Gingiva / Q000378:metabolism; D006023:Glycoproteins / Q000096:biosynthesis*; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D010281:Parathyroid Hormone / Q000494:pharmacology; D014176:Protein Biosynthesis; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D019716:Tissue Inhibitor of Metalloproteinase-2; D019714:Tissue Inhibitor of Metalloproteinases; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
D006023:Glycoproteins; D010281:Parathyroid Hormone; D019714:Tissue Inhibitor of Metalloproteinases; D016212:Transforming Growth Factor beta; D003208:Concanavalin A; D019716:Tissue Inhibitor of Metalloproteinase-2; D014212:Tretinoin; D008666:Metalloendopeptidases; D013755:Tetradecanoylphorbol Acetate